For more, check out this other research from our platform: Ro (dataset) Ro and the telehealth capital cycle Hone Health at $114M ARR growing 82% YoY Rula at $471M/year growing 100% YoY Function Health at $100M/year Maven Clinic at $268M ARR Commure at $105M ARR Virta Health at $175M revenue Noom at $1B ARR Hone Health: the $55M/year D2C testosterone startup Swedens $215M/year telehealth giant Johannes Schildt & Claes Ruth, CEO and CFO of Kry, on the AI future of telehealth Marc Atiyeh, CEO of Pawp, on building telehealth for pets Brendan Keeler, Senior PM at Zus Health, on building infrastructure for digital health Noom at $1B ARR
Historically, PFOA and PFOS have been used in a range of consumer products and industrial applications, including nonstick cookware and firefighting foams
doi: 10.1139/apnm-2016-0094
These higher doses activate GLP-1 receptors more effectively, signaling fullness to your brain and reducing hunger-driven eating patterns
Tirzepatide may provide more rapid early weight reduction at lower doses, whereas semaglutide may allow continued titration with incremental benefit at higher doses, particularly in patients who tolerate therapy well and require additional weight loss
Source: Drucker, 2025 What began as a much-discussed incretin effect has now evolved into a 'supermedication' with far-reaching impacts across multiple organ systems
-1.png)
